RVL Pharmaceuticals plc Income (Loss) from Continuing Operations, Per Basic Share
RVL Pharmaceuticals plc reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.58 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2023-03-20
- RVL Pharmaceuticals plc income (loss) from continuing operations, per basic share for the quarter ending 2022-09-30 was -$0.16.
- RVL Pharmaceuticals plc income (loss) from continuing operations, per basic share for the quarter ending 2022-06-30 was -$0.14.
- RVL Pharmaceuticals plc income (loss) from continuing operations, per basic share for the quarter ending 2022-03-31 was -$0.08.
- RVL Pharmaceuticals plc income (loss) from continuing operations, per basic share for the quarter ending 2021-09-30 was -$0.42, a 1500.00% decline year-over-year.
- RVL Pharmaceuticals plc income (loss) from continuing operations, per basic share for fiscal 2022 was -$0.58.
- RVL Pharmaceuticals plc income (loss) from continuing operations, per basic share for fiscal 2021 was -$1.23.
- RVL Pharmaceuticals plc income (loss) from continuing operations, per basic share for fiscal 2020 was -$1.47.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$0.58 10-K · filed 2023-03-20 | |||
| 2022-09-30 | -$0.16 10-Q · filed 2022-11-10 | -$0.39 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | -$0.14 10-Q · filed 2022-08-11 | -$0.23 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | -$0.08 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | -$1.23 10-K · filed 2023-03-20 | |||
| 2021-09-30 | -$0.42 10-Q · filed 2022-11-10 | -$1.01 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.35 10-Q · filed 2022-08-11 | -$0.57 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$0.22 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$1.47 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $0.03 10-Q · filed 2021-11-15 | -$0.62 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$0.30 10-Q · filed 2021-08-16 | -$0.66 10-Q · filed 2021-08-16 |